Guidelines Bring New Strategy in Low-Risk AF

2012 ◽  
Vol 45 (15) ◽  
pp. 12-13
Author(s):  
BRUCE JANCIN
Keyword(s):  
Low Risk ◽  
2017 ◽  
Vol 55 (8) ◽  
pp. 1209-1214 ◽  
Author(s):  
Tae-Dong Jeong ◽  
Eun-Jung Cho ◽  
Dae-Hyun Ko ◽  
Woochang Lee ◽  
Sail Chun ◽  
...  

Abstract Background: Reliable quantitative measurements of HE4 and CA125 levels are required to calculate the risk of ovarian malignancy algorithm (ROMA) value. We suggest a new reporting strategy for interpreting ROMA values based on analytical measurement range (AMR) and qualified-intervals of the HE4 and CA125 results. Methods: HE4 and CA125 assays from Abbott and Roche were used. The AMRs and the qualified-intervals were as follows: Architect HE4 assay, 20–1500 and 17.2–2637.8 pmol/L; Architect CA125 II assay, 1–1000 and 3.9–14,163.0 U/mL; Elecsys HE4 assay, 15–1500 and 28.8–3847 pmol/L; Elecsys CA125 II assay, 0.6–5000 and 6.5–5000 U/mL. These values were used to simulate the ROMA values. Results: Reporting algorithm for the ROMA value could be classified into three categories. (1) If quantitative HE4 and CA125 levels are reliable, the numerical ROMA value can be reported. (2) If HE4 value is <20 and <28.8 for Abbott and Roche in premenopausal woman, the ROMA value should be reported as “low risk” regardless of the CA125 result. In postmenopausal woman, however, it should be reported as “low risk” (CA125<203.0 and <165.8 for Abbott and Roche) or “undetermined” (vice-versa value). (3) If CA125 value is <3.9 and <6.5 for Abbott and Roche, it should be reported as “low risk” (premenopausal HE4<51.5 and <62.2, postmenopausal HE4<323.0 and <281.5 for Abbott and Roche) or “undetermined” (vice-versa value). Conclusions: New reporting strategy will provide more informative reporting of ROMA values in clinical practice.


2012 ◽  
Vol 42 (16) ◽  
pp. 6
Author(s):  
BRUCE JANCIN
Keyword(s):  
Low Risk ◽  

2018 ◽  
Vol 11 (1) ◽  
pp. 149
Author(s):  
Roberto B. O. Ponce ◽  
Laércio Zambolim ◽  
Antonio A. Fortunato ◽  
Luan F.de Queiroz

Asian soybean rust (ASR) caused by Phakopsora pachyrhizi since it was first reported in Brazil in 2001 has been subject of studies regarding the use of fungicides to its control. Low efficiency of triazol (demethylator inhibitors-DMI&rsquo;s) or stobilurin (quinone outside inhibitor-QoI&rsquo;s) has been reported on the control of ASR under field conditons. For this reason experiments were conducted to study the effects of these systemic fungicides associate with protectant multi-site fungicides (MSF) on ASR control preventively and at the onset of the epidemic. All combinations of fungicides were effective to control ASR and promoted greater soybean yield gain compared to the control. The analysis of the efficacy of ASR control in the lower, medium and upper part of the plant canopy, showed that application of Epoxiconazole + Pyraclostrobin and Cyproconazole + Azoxystrobin reduced ASR and leaf fall (%), and increased soybean yield grain. The severity of the disease increased from the lower to the upper part of the plant. The application of DMI+ QoI associated with MSF applyed when disease severity reached 2%, promoted effective reduction of ASR, increased yield and reduced leaf fall. Overal the DMI&rsquo;s + QoI&rsquo;s associated with MSF was 68% and 70.2% more efficient on ASR control and soybean grain yield, respectively than the control. Mancozeb and Chlorothalonil associated with the lowest dose of Epoxiconazol + Pyraclostrobin (10.2 + 33.2 g.a.i./ha) or Cyproconazole + Azoxystrobin (12.5 + 30.0 g.a.i./ha), respectively increased soybean grain yield at least 45.0%; the same combinations of the fungicides Epoxiconazol + Pyraclostrobin (15.3 + 49.8 g.a.i./ha) and Cyproconazole + Azoxystrobin (25.0 + 60.0 g.a.i./ha) 50% less than the commercial dose, increased 89.5% and 109.0%, respectively. The use of high risk (DMI and QoI) fungicides combined to low risk (MSF) applyied properly, can be a new strategy for the management of ASR at short and long term, even after the epidemics has reached 2.0% severity. Furthermore, due to the residual effect, MSF can promote higher longevity of DMI and QoI molecules.


2020 ◽  
Vol 29 (4) ◽  
pp. 1944-1955 ◽  
Author(s):  
Maria Schwarz ◽  
Elizabeth C. Ward ◽  
Petrea Cornwell ◽  
Anne Coccetti ◽  
Pamela D'Netto ◽  
...  

Purpose The purpose of this study was to examine (a) the agreement between allied health assistants (AHAs) and speech-language pathologists (SLPs) when completing dysphagia screening for low-risk referrals and at-risk patients under a delegation model and (b) the operational impact of this delegation model. Method All AHAs worked in the adult acute inpatient settings across three hospitals and completed training and competency evaluation prior to conducting independent screening. Screening (pass/fail) was based on results from pre-screening exclusionary questions in combination with a water swallow test and the Eating Assessment Tool. To examine the agreement of AHAs' decision making with SLPs, AHAs ( n = 7) and SLPs ( n = 8) conducted an independent, simultaneous dysphagia screening on 51 adult inpatients classified as low-risk/at-risk referrals. To examine operational impact, AHAs independently completed screening on 48 low-risk/at-risk patients, with subsequent clinical swallow evaluation conducted by an SLP with patients who failed screening. Results Exact agreement between AHAs and SLPs on overall pass/fail screening criteria for the first 51 patients was 100%. Exact agreement for the two tools was 100% for the Eating Assessment Tool and 96% for the water swallow test. In the operational impact phase ( n = 48), 58% of patients failed AHA screening, with only 10% false positives on subjective SLP assessment and nil identified false negatives. Conclusion AHAs demonstrated the ability to reliably conduct dysphagia screening on a cohort of low-risk patients, with a low rate of false negatives. Data support high level of agreement and positive operational impact of using trained AHAs to perform dysphagia screening in low-risk patients.


Haemophilia ◽  
2001 ◽  
Vol 7 (4) ◽  
pp. 416-418 ◽  
Author(s):  
M. Acquila ◽  
F. Bottini ◽  
A. Valetto ◽  
D. Caprino ◽  
P. G. Mori ◽  
...  

2008 ◽  
Vol 41 (15) ◽  
pp. 41
Author(s):  
ALICIA AULT
Keyword(s):  

2011 ◽  
Vol 44 (17) ◽  
pp. 24
Author(s):  
HEIDI SPLETE
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document